Persistent increased Epstein-Barr virus loads after solid organ transplantation: Truth and consequences?

Liver Transplantation

Volumn 13, Issue 3, 2007, Pages 321-322

  Green, Michael ^a   Webber, Steven A ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ACUTE GRAFT REJECTION; BURKITT LYMPHOMA; CELLULAR IMMUNITY; EARLY DIAGNOSIS; EDITORIAL; EPSTEIN BARR VIRUS; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; PERIPHERAL LYMPHOCYTE; POSTOPERATIVE INFECTION; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; VIRUS DETECTION; VIRUS LOAD;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; GRAFT REJECTION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MONITORING, IMMUNOLOGIC; ORGAN TRANSPLANTATION; VIRAL LOAD;

EID: 33947358305     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21015     Document Type: Editorial

References (9)

1. Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transplant Infect Dis 2001:3:70-78.
2. Funch DP, Walker AM, Schneider G, Ziyadeh NH. Pescovitz MD. Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients. Am J Transplant 2005:5:2894-2900,
3. Malatach JF, Gartner JC Jr. Urbach AH, Zitelli BJ. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: a growing concern. J Pediatr 1991;118:667-675.
4. McDiarmid SV, Jordan S, Kim GS, Toyoda M, Goss JA, Vargas JH, et al. Prevention and preemptive therapy of post-transplant lymphoproliferative disease in pediatric liver transplant recipients. Transplantation 1998;66:1604-1611.
5. Green M, Reyes J, Webber S, Michaels MG, Rowe D. The role of viral load in the diagnosis, management. and possible prevention of Epstein Barr virus-associated postransplant lymphoproliferative disease following solid Organ transplantation Curr Opin Organ Transpl 1999:4:292-296.
6. Green M, Caccuarelli TV, Mazareigos GV, Sigurdsson L, Qu L, Rowe DT, et al. Serial measurements of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttranslant lymphoproliferative disease. Transplantation 1998;66:1641-1644.
7. D'Antiga L, Del Rizzo M, Mengoli C, Cillio U. Guariso G, Zancan L. Sustained Epstein-Barr virus detection in pediatric liver transplantation: insights into the occurrence of late PTLD. Liver Transpl 2007;13;343-348.
8. Qu L, Green M, Webber S, Reyes J, Ellis D, Rowe D. Epstein-Barr virus gene expression in the pheripheral blood of transplant recipients with chronic circulating viral loads. J Infect Dis 2000;182:1013-1021.
9. Bingler MA, Miller SA, Boyle GJ, Michaels MG, Green M. Wadowsky FM. Rowe DT, et al. Chronic high Epstein-Barr virus load carrier state and risk for late onset PTLD/malignant lymphoma. Paper presented at: International Society for Heart and Lung Transplantation; April 2005: Philadelphia, PA: and International Pediatric Transplant Association, 3rd World Congress; August 2005; Innsbruck. Austria.